Umbrella Brand Debate Lives On At FDA Naming Workshop
This article was originally published in The Tan Sheet
Executive Summary
Critics of drug labels' effectiveness say reducing errors in the use of OTC drugs depends largely on a change manufacturers oppose - reining in umbrella branding